Drug Trial Radar · NCT04597801
Comparison of Fluorescein-INtra-VItal Microscopy Versus Conventional Frozen Section Diagnosis for intraOperative Histopathological Evaluation
Last checked: Nov 19, 2026Latest source record: Nov 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
210
Actual
Start
Dec 30, 2020
Primary completion
Jun 17, 2022
Study completion Aug 3, 2022
Sponsor
- Lead sponsor
- Technical University of MunichAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Carl Zeiss Meditec AG
- First posted
- Oct 22, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
With the appliance of the in-vivo microscopy after Fluorescein staining, the investigators hypothesize that the preliminary in-vivo histopathological diagnostic accuracy is not inferior to conventional frozen section analysis accuracy when using the final histopathological result as gold standard.
Conditions
- Intracranial Tumor
Interventions
AlconDrug
Fluorescein sodium is administered intravenously with a bolus injection of 5 mg per kg of bodyweight 20-40 minutes prior to the planned tumor resection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Significance: The diagnostic accuracies of the individual methods used for preliminary intraoperative histopathological diagnosis (D1:fluorescein sodium with in-vivo microscopy versus D2: preliminary frozen section assessment)Time frame: 14 days
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Universitätsklinikum Mannheim
Mannheim, Germany
Technische Universität München, Klinik und Poliklinik für Neurochirurgie
München, Germany
Universitätsklinikum Regensburg
Regensburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.